Prevalence of founderBRCA1 andBRCA2 mutations among breast and ovarian cancer patients in hungary
Open Access
- 27 April 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 86 (5) , 737-740
- https://doi.org/10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Germline BRCA1 alterations in a population-based series of ovarian cancer cases.Human Molecular Genetics, 1999
- Frequency of BRCA1 Mutation 5382insC in German Breast Cancer PatientsGynecologic Oncology, 1999
- Strong founder effects in BRCA1 mutation carrier breast cancer patients from LatviaHuman Mutation, 1999
- Haplotype and Phenotype Analysis of Nine Recurrent BRCA2 Mutations in 111 Families: Results of an International StudyAmerican Journal of Human Genetics, 1998
- Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic casesThe Lancet, 1997
- Tumour biological features of BRCA1-induced breast and ovarian cancerEuropean Journal Of Cancer, 1997
- A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2Nature Genetics, 1997
- Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNature Genetics, 1994